HIV/AIDS: FEASIBILITY AND ACCEPTABILITY OF DAILY ORAL EMTRICITABINE AND TENOFOVIR ALAFENAMIDE FUMARATE (FTC/TAF) FOR HIV PRE-EXPOSURE PROPHYLAXIS AMONG OPIOID-DEPENDENT PEOPLE WHO INJECT DRUGS
Publication
, Conference
Gautam, K; Paudel, K; Wickersham, JA; Bellia, G; Altice, FL; JadKarim, L; Liew, Z; Khati, A; Copenhaver, M; Shrestha, R
Published in: ANNALS OF BEHAVIORAL MEDICINE
June 2025
Duke Scholars
Published In
ANNALS OF BEHAVIORAL MEDICINE
EISSN
1532-4796
ISSN
0883-6612
Publication Date
June 2025
Volume
59
Start / End Page
S231 / S231
Related Subject Headings
- Public Health
- 52 Psychology
- 42 Health sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Gautam, K., Paudel, K., Wickersham, J. A., Bellia, G., Altice, F. L., JadKarim, L., … Shrestha, R. (2025). HIV/AIDS: FEASIBILITY AND ACCEPTABILITY OF DAILY ORAL EMTRICITABINE AND TENOFOVIR ALAFENAMIDE FUMARATE (FTC/TAF) FOR HIV PRE-EXPOSURE PROPHYLAXIS AMONG OPIOID-DEPENDENT PEOPLE WHO INJECT DRUGS. In ANNALS OF BEHAVIORAL MEDICINE (Vol. 59, pp. S231–S231).
Gautam, Kamal, Kiran Paudel, Jeffrey A. Wickersham, Giselle Bellia, Frederick L. Altice, Luzan JadKarim, Zeyan Liew, Antoine Khati, Michael Copenhaver, and Roman Shrestha. “HIV/AIDS: FEASIBILITY AND ACCEPTABILITY OF DAILY ORAL EMTRICITABINE AND TENOFOVIR ALAFENAMIDE FUMARATE (FTC/TAF) FOR HIV PRE-EXPOSURE PROPHYLAXIS AMONG OPIOID-DEPENDENT PEOPLE WHO INJECT DRUGS.” In ANNALS OF BEHAVIORAL MEDICINE, 59:S231–S231, 2025.
Gautam K, Paudel K, Wickersham JA, Bellia G, Altice FL, JadKarim L, et al. HIV/AIDS: FEASIBILITY AND ACCEPTABILITY OF DAILY ORAL EMTRICITABINE AND TENOFOVIR ALAFENAMIDE FUMARATE (FTC/TAF) FOR HIV PRE-EXPOSURE PROPHYLAXIS AMONG OPIOID-DEPENDENT PEOPLE WHO INJECT DRUGS. In: ANNALS OF BEHAVIORAL MEDICINE. 2025. p. S231–S231.
Gautam, Kamal, et al. “HIV/AIDS: FEASIBILITY AND ACCEPTABILITY OF DAILY ORAL EMTRICITABINE AND TENOFOVIR ALAFENAMIDE FUMARATE (FTC/TAF) FOR HIV PRE-EXPOSURE PROPHYLAXIS AMONG OPIOID-DEPENDENT PEOPLE WHO INJECT DRUGS.” ANNALS OF BEHAVIORAL MEDICINE, vol. 59, 2025, pp. S231–S231.
Gautam K, Paudel K, Wickersham JA, Bellia G, Altice FL, JadKarim L, Liew Z, Khati A, Copenhaver M, Shrestha R. HIV/AIDS: FEASIBILITY AND ACCEPTABILITY OF DAILY ORAL EMTRICITABINE AND TENOFOVIR ALAFENAMIDE FUMARATE (FTC/TAF) FOR HIV PRE-EXPOSURE PROPHYLAXIS AMONG OPIOID-DEPENDENT PEOPLE WHO INJECT DRUGS. ANNALS OF BEHAVIORAL MEDICINE. 2025. p. S231–S231.
Published In
ANNALS OF BEHAVIORAL MEDICINE
EISSN
1532-4796
ISSN
0883-6612
Publication Date
June 2025
Volume
59
Start / End Page
S231 / S231
Related Subject Headings
- Public Health
- 52 Psychology
- 42 Health sciences